I earned my Ph.D. from the University of Pécs and then continued my academic career as a postdoctoral research scientist at Columbia University, where I was promoted to Associate Research Scientist in 2015. During my time at Columbia, I conducted preclinical in vitro and in vivo testing of new small molecules for the treatment of Stargardt disease and age-related macular degeneration.
In Dr. Heller’s Cancer Nanomedicine Laboratory at MSKCC, we focus on developing nanotechnologies to improve research, diagnosis, and treatment of cancer and related diseases. Our work includes creating drug delivery systems that target therapies directly to disease sites, enhancing diagnostic methods for earlier detection, and designing nanosensors to speed up the discovery of new treatments.